nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—ADRA2A—type 2 diabetes mellitus	0.0956	0.263	CbGaD
Iloperidone—HTR2C—type 2 diabetes mellitus	0.088	0.242	CbGaD
Iloperidone—CYP2E1—type 2 diabetes mellitus	0.0698	0.192	CbGaD
Iloperidone—CYP1A2—type 2 diabetes mellitus	0.0664	0.182	CbGaD
Iloperidone—CYP3A4—type 2 diabetes mellitus	0.044	0.121	CbGaD
Iloperidone—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0324	0.0789	CbGbCtD
Iloperidone—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0315	0.0767	CbGbCtD
Iloperidone—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0284	0.0692	CbGbCtD
Iloperidone—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0259	0.0631	CbGbCtD
Iloperidone—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0234	0.057	CbGbCtD
Iloperidone—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0226	0.055	CbGbCtD
Iloperidone—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0226	0.055	CbGbCtD
Iloperidone—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0165	0.0402	CbGbCtD
Iloperidone—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0156	0.0379	CbGbCtD
Iloperidone—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0149	0.0363	CbGbCtD
Iloperidone—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0149	0.0363	CbGbCtD
Iloperidone—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0143	0.0348	CbGbCtD
Iloperidone—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0137	0.0334	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0119	0.0289	CbGbCtD
Iloperidone—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0119	0.0289	CbGbCtD
Iloperidone—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0089	0.0217	CbGbCtD
Iloperidone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00807	0.0197	CbGbCtD
Iloperidone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0072	0.0176	CbGbCtD
Iloperidone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00711	0.0173	CbGbCtD
Iloperidone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00665	0.0162	CbGbCtD
Iloperidone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00635	0.0155	CbGbCtD
Iloperidone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00633	0.0154	CbGbCtD
Iloperidone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00601	0.0146	CbGbCtD
Iloperidone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00579	0.0141	CbGbCtD
Iloperidone—CYP3A5—Losartan—type 2 diabetes mellitus	0.0055	0.0134	CbGbCtD
Iloperidone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00546	0.0133	CbGbCtD
Iloperidone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00523	0.0128	CbGbCtD
Iloperidone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00506	0.0123	CbGbCtD
Iloperidone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00458	0.0112	CbGbCtD
Iloperidone—CYP1A2—Losartan—type 2 diabetes mellitus	0.00409	0.00997	CbGbCtD
Iloperidone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00347	0.00846	CbGbCtD
Iloperidone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00333	0.00811	CbGbCtD
Iloperidone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00333	0.00811	CbGbCtD
Iloperidone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00315	0.00767	CbGbCtD
Iloperidone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00234	0.00571	CbGbCtD
Iloperidone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00214	0.00523	CbGbCtD
Iloperidone—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00209	0.0695	CbGeAlD
Iloperidone—HTR2A—arteriole—type 2 diabetes mellitus	0.00204	0.068	CbGeAlD
Iloperidone—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.0014	0.0467	CbGeAlD
Iloperidone—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0013	0.0433	CbGeAlD
Iloperidone—DRD1—nerve—type 2 diabetes mellitus	0.00126	0.042	CbGeAlD
Iloperidone—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00101	0.0337	CbGeAlD
Iloperidone—HTR1D—artery—type 2 diabetes mellitus	0.000999	0.0333	CbGeAlD
Iloperidone—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000875	0.0291	CbGeAlD
Iloperidone—HTR2A—hindlimb—type 2 diabetes mellitus	0.000809	0.0269	CbGeAlD
Iloperidone—HTR7—artery—type 2 diabetes mellitus	0.000795	0.0265	CbGeAlD
Iloperidone—HTR7—nerve—type 2 diabetes mellitus	0.000789	0.0263	CbGeAlD
Iloperidone—DRD2—nerve—type 2 diabetes mellitus	0.000746	0.0248	CbGeAlD
Iloperidone—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000742	0.0247	CbGeAlD
Iloperidone—HTR7—endothelium—type 2 diabetes mellitus	0.000672	0.0224	CbGeAlD
Iloperidone—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000631	0.021	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000572	0.019	CbGeAlD
Iloperidone—HTR2A—artery—type 2 diabetes mellitus	0.000496	0.0165	CbGeAlD
Iloperidone—HTR2A—nerve—type 2 diabetes mellitus	0.000492	0.0164	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.00049	0.0163	CbGeAlD
Iloperidone—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000447	0.0149	CbGeAlD
Iloperidone—Paliperidone—ADRA2A—type 2 diabetes mellitus	0.000442	0.147	CrCbGaD
Iloperidone—HTR2A—endothelium—type 2 diabetes mellitus	0.000419	0.014	CbGeAlD
Iloperidone—Paliperidone—HTR2C—type 2 diabetes mellitus	0.000407	0.135	CrCbGaD
Iloperidone—CYP3A7—liver—type 2 diabetes mellitus	0.000374	0.0124	CbGeAlD
Iloperidone—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.00036	0.012	CbGeAlD
Iloperidone—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000347	0.0116	CbGeAlD
Iloperidone—HTR1D—kidney—type 2 diabetes mellitus	0.00034	0.0113	CbGeAlD
Iloperidone—Risperidone—ADRA2A—type 2 diabetes mellitus	0.00033	0.11	CrCbGaD
Iloperidone—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000318	0.0106	CbGeAlD
Iloperidone—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000314	0.0105	CbGeAlD
Iloperidone—DRD2—retina—type 2 diabetes mellitus	0.000309	0.0103	CbGeAlD
Iloperidone—Cisapride—HTR2C—type 2 diabetes mellitus	0.000308	0.103	CrCbGaD
Iloperidone—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000308	0.0103	CbGeAlD
Iloperidone—Risperidone—HTR2C—type 2 diabetes mellitus	0.000303	0.101	CrCbGaD
Iloperidone—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000294	0.00979	CbGeAlD
Iloperidone—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000289	0.00963	CbGeAlD
Iloperidone—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000285	0.0095	CbGeAlD
Iloperidone—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000283	0.00942	CbGeAlD
Iloperidone—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.00028	0.00933	CbGeAlD
Iloperidone—Gefitinib—EGFR—type 2 diabetes mellitus	0.00028	0.0933	CrCbGaD
Iloperidone—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000276	0.0092	CbGeAlD
Iloperidone—HTR7—kidney—type 2 diabetes mellitus	0.00027	0.00901	CbGeAlD
Iloperidone—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000267	0.00888	CbGeAlD
Iloperidone—ADRA2C—kidney—type 2 diabetes mellitus	0.000249	0.00828	CbGeAlD
Iloperidone—ADRA2C—pancreas—type 2 diabetes mellitus	0.000247	0.00822	CbGeAlD
Iloperidone—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000242	0.00806	CbGeAlD
Iloperidone—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000237	0.00788	CbGeAlD
Iloperidone—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000235	0.00783	CbGeAlD
Iloperidone—Cisapride—CYP1A2—type 2 diabetes mellitus	0.000233	0.0775	CrCbGaD
Iloperidone—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000224	0.00746	CbGeAlD
Iloperidone—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000221	0.00735	CbGeAlD
Iloperidone—CYP3A5—kidney—type 2 diabetes mellitus	0.000208	0.00693	CbGeAlD
Iloperidone—CYP3A5—pancreas—type 2 diabetes mellitus	0.000207	0.00688	CbGeAlD
Iloperidone—HTR2A—retina—type 2 diabetes mellitus	0.000204	0.00679	CbGeAlD
Iloperidone—Paliperidone—CYP3A4—type 2 diabetes mellitus	0.000203	0.0677	CrCbGaD
Iloperidone—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000203	0.00675	CbGeAlD
Iloperidone—SIGMAR1—liver—type 2 diabetes mellitus	0.0002	0.00666	CbGeAlD
Iloperidone—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000198	0.0066	CbGeAlD
Iloperidone—ADRA2A—pancreas—type 2 diabetes mellitus	0.000197	0.00656	CbGeAlD
Iloperidone—CYP2E1—kidney—type 2 diabetes mellitus	0.000194	0.00646	CbGeAlD
Iloperidone—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000193	0.00643	CbGeAlD
Iloperidone—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000189	0.00629	CbGeAlD
Iloperidone—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000188	0.00624	CbGeAlD
Iloperidone—HRH1—adipose tissue—type 2 diabetes mellitus	0.000182	0.00606	CbGeAlD
Iloperidone—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000179	0.00595	CbGeAlD
Iloperidone—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000172	0.00574	CbGeAlD
Iloperidone—HTR7—liver—type 2 diabetes mellitus	0.000171	0.00569	CbGeAlD
Iloperidone—HTR2A—kidney—type 2 diabetes mellitus	0.000169	0.00562	CbGeAlD
Iloperidone—ADRA1A—liver—type 2 diabetes mellitus	0.000165	0.00549	CbGeAlD
Iloperidone—ADRA2C—liver—type 2 diabetes mellitus	0.000157	0.00523	CbGeAlD
Iloperidone—CYP3A4—kidney—type 2 diabetes mellitus	0.000156	0.0052	CbGeAlD
Iloperidone—Cisapride—CYP3A4—type 2 diabetes mellitus	0.000154	0.0513	CrCbGaD
Iloperidone—CYP2D6—kidney—type 2 diabetes mellitus	0.000154	0.00512	CbGeAlD
Iloperidone—Risperidone—CYP3A4—type 2 diabetes mellitus	0.000152	0.0505	CrCbGaD
Iloperidone—CYP1A2—liver—type 2 diabetes mellitus	0.000136	0.00454	CbGeAlD
Iloperidone—CYP3A5—liver—type 2 diabetes mellitus	0.000132	0.00438	CbGeAlD
Iloperidone—CYP2E1—liver—type 2 diabetes mellitus	0.000123	0.00408	CbGeAlD
Iloperidone—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00108	CcSEcCtD
Iloperidone—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Iloperidone—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00012	0.00107	CcSEcCtD
Iloperidone—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000119	0.00107	CcSEcCtD
Iloperidone—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000119	0.00106	CcSEcCtD
Iloperidone—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000118	0.00106	CcSEcCtD
Iloperidone—Angiopathy—Metformin—type 2 diabetes mellitus	0.000118	0.00106	CcSEcCtD
Iloperidone—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000117	0.00105	CcSEcCtD
Iloperidone—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000117	0.00105	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
Iloperidone—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
Iloperidone—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000116	0.00104	CcSEcCtD
Iloperidone—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Hypotension—Glyburide—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000115	0.00103	CcSEcCtD
Iloperidone—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000114	0.00103	CcSEcCtD
Iloperidone—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
Iloperidone—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000114	0.00102	CcSEcCtD
Iloperidone—Malnutrition—Metformin—type 2 diabetes mellitus	0.000113	0.00102	CcSEcCtD
Iloperidone—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
Iloperidone—Weight increased—Ramipril—type 2 diabetes mellitus	0.000113	0.00101	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000112	0.00101	CcSEcCtD
Iloperidone—Vertigo—Valsartan—type 2 diabetes mellitus	0.000112	0.001	CcSEcCtD
Iloperidone—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000111	0.000999	CcSEcCtD
Iloperidone—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000111	0.000999	CcSEcCtD
Iloperidone—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000111	0.000995	CcSEcCtD
Iloperidone—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000111	0.000993	CcSEcCtD
Iloperidone—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00011	0.000991	CcSEcCtD
Iloperidone—Vertigo—Orlistat—type 2 diabetes mellitus	0.00011	0.000991	CcSEcCtD
Iloperidone—Palpitations—Valsartan—type 2 diabetes mellitus	0.00011	0.000986	CcSEcCtD
Iloperidone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00011	0.000986	CcSEcCtD
Iloperidone—Infection—Gliclazide—type 2 diabetes mellitus	0.00011	0.000985	CcSEcCtD
Iloperidone—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00011	0.000984	CcSEcCtD
Iloperidone—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000984	CcSEcCtD
Iloperidone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000109	0.000981	CcSEcCtD
Iloperidone—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000109	0.000977	CcSEcCtD
Iloperidone—Palpitations—Orlistat—type 2 diabetes mellitus	0.000109	0.000974	CcSEcCtD
Iloperidone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000108	0.000973	CcSEcCtD
Iloperidone—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000108	0.000972	CcSEcCtD
Iloperidone—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000967	CcSEcCtD
Iloperidone—Tinnitus—Losartan—type 2 diabetes mellitus	0.000108	0.000967	CcSEcCtD
Iloperidone—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000107	0.000965	CcSEcCtD
Iloperidone—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000107	0.000962	CcSEcCtD
Iloperidone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000107	0.00096	CcSEcCtD
Iloperidone—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000107	0.000959	CcSEcCtD
Iloperidone—Vision blurred—Metformin—type 2 diabetes mellitus	0.000107	0.000958	CcSEcCtD
Iloperidone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000957	CcSEcCtD
Iloperidone—HTR2A—liver—type 2 diabetes mellitus	0.000107	0.00355	CbGeAlD
Iloperidone—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000955	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000106	0.000953	CcSEcCtD
Iloperidone—Tremor—Metformin—type 2 diabetes mellitus	0.000106	0.000952	CcSEcCtD
Iloperidone—Myalgia—Valsartan—type 2 diabetes mellitus	0.000106	0.00095	CcSEcCtD
Iloperidone—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000106	0.00095	CcSEcCtD
Iloperidone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000106	0.000948	CcSEcCtD
Iloperidone—Angiopathy—Losartan—type 2 diabetes mellitus	0.000105	0.000941	CcSEcCtD
Iloperidone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000105	0.00094	CcSEcCtD
Iloperidone—Myalgia—Orlistat—type 2 diabetes mellitus	0.000105	0.000939	CcSEcCtD
Iloperidone—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000104	0.000936	CcSEcCtD
Iloperidone—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000104	0.000934	CcSEcCtD
Iloperidone—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000103	0.000929	CcSEcCtD
Iloperidone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000103	0.000926	CcSEcCtD
Iloperidone—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000103	0.000926	CcSEcCtD
Iloperidone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000103	0.000922	CcSEcCtD
Iloperidone—Gefitinib—CYP3A4—type 2 diabetes mellitus	0.000102	0.0341	CrCbGaD
Iloperidone—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000102	0.000918	CcSEcCtD
Iloperidone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000102	0.000916	CcSEcCtD
Iloperidone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000102	0.000913	CcSEcCtD
Iloperidone—Oedema—Valsartan—type 2 diabetes mellitus	0.000101	0.000911	CcSEcCtD
Iloperidone—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000101	0.00091	CcSEcCtD
Iloperidone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000101	0.000909	CcSEcCtD
Iloperidone—Infection—Valsartan—type 2 diabetes mellitus	0.000101	0.000905	CcSEcCtD
Iloperidone—Rash—Glipizide—type 2 diabetes mellitus	0.000101	0.000904	CcSEcCtD
Iloperidone—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000101	0.000904	CcSEcCtD
Iloperidone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000101	0.000904	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000101	0.000903	CcSEcCtD
Iloperidone—Oedema—Orlistat—type 2 diabetes mellitus	0.0001	0.0009	CcSEcCtD
Iloperidone—Tremor—Irbesartan—type 2 diabetes mellitus	0.0001	0.000898	CcSEcCtD
Iloperidone—Palpitations—Metformin—type 2 diabetes mellitus	0.0001	0.000898	CcSEcCtD
Iloperidone—Infection—Orlistat—type 2 diabetes mellitus	9.96e-05	0.000894	CcSEcCtD
Iloperidone—Nervous system disorder—Valsartan—type 2 diabetes mellitus	9.95e-05	0.000893	CcSEcCtD
Iloperidone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	9.91e-05	0.00089	CcSEcCtD
Iloperidone—Anaemia—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000886	CcSEcCtD
Iloperidone—CYP3A4—liver—type 2 diabetes mellitus	9.87e-05	0.00329	CbGeAlD
Iloperidone—Dizziness—Glimepiride—type 2 diabetes mellitus	9.86e-05	0.000885	CcSEcCtD
Iloperidone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000884	CcSEcCtD
Iloperidone—Nervous system disorder—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000882	CcSEcCtD
Iloperidone—Dizziness—Sitagliptin—type 2 diabetes mellitus	9.83e-05	0.000882	CcSEcCtD
Iloperidone—Agitation—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.000881	CcSEcCtD
Iloperidone—Somnolence—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.000881	CcSEcCtD
Iloperidone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000874	CcSEcCtD
Iloperidone—CYP2D6—liver—type 2 diabetes mellitus	9.71e-05	0.00323	CbGeAlD
Iloperidone—Muscle spasms—Losartan—type 2 diabetes mellitus	9.66e-05	0.000868	CcSEcCtD
Iloperidone—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.65e-05	0.000866	CcSEcCtD
Iloperidone—Myalgia—Metformin—type 2 diabetes mellitus	9.63e-05	0.000865	CcSEcCtD
Iloperidone—Vertigo—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000862	CcSEcCtD
Iloperidone—Leukopenia—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000858	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.53e-05	0.000856	CcSEcCtD
Iloperidone—Fatigue—Gliclazide—type 2 diabetes mellitus	9.52e-05	0.000855	CcSEcCtD
Iloperidone—Nausea—Glipizide—type 2 diabetes mellitus	9.49e-05	0.000852	CcSEcCtD
Iloperidone—Hypotension—Valsartan—type 2 diabetes mellitus	9.48e-05	0.000851	CcSEcCtD
Iloperidone—Vision blurred—Losartan—type 2 diabetes mellitus	9.47e-05	0.00085	CcSEcCtD
Iloperidone—Tremor—Losartan—type 2 diabetes mellitus	9.42e-05	0.000845	CcSEcCtD
Iloperidone—Rash—Glimepiride—type 2 diabetes mellitus	9.4e-05	0.000844	CcSEcCtD
Iloperidone—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.39e-05	0.000843	CcSEcCtD
Iloperidone—Rash—Sitagliptin—type 2 diabetes mellitus	9.37e-05	0.000841	CcSEcCtD
Iloperidone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.36e-05	0.00084	CcSEcCtD
Iloperidone—Anaemia—Losartan—type 2 diabetes mellitus	9.29e-05	0.000834	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.24e-05	0.00083	CcSEcCtD
Iloperidone—Agitation—Losartan—type 2 diabetes mellitus	9.24e-05	0.000829	CcSEcCtD
Iloperidone—Oedema—Metformin—type 2 diabetes mellitus	9.24e-05	0.000829	CcSEcCtD
Iloperidone—Tinnitus—Ramipril—type 2 diabetes mellitus	9.23e-05	0.000829	CcSEcCtD
Iloperidone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.2e-05	0.000826	CcSEcCtD
Iloperidone—Infection—Metformin—type 2 diabetes mellitus	9.18e-05	0.000824	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.13e-05	0.00082	CcSEcCtD
Iloperidone—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.11e-05	0.000818	CcSEcCtD
Iloperidone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.1e-05	0.000817	CcSEcCtD
Iloperidone—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000816	CcSEcCtD
Iloperidone—Myalgia—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000816	CcSEcCtD
Iloperidone—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.06e-05	0.000813	CcSEcCtD
Iloperidone—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000812	CcSEcCtD
Iloperidone—Vertigo—Losartan—type 2 diabetes mellitus	9.03e-05	0.000811	CcSEcCtD
Iloperidone—Somnolence—Valsartan—type 2 diabetes mellitus	9.02e-05	0.00081	CcSEcCtD
Iloperidone—Paraesthesia—Orlistat—type 2 diabetes mellitus	9e-05	0.000808	CcSEcCtD
Iloperidone—Leukopenia—Losartan—type 2 diabetes mellitus	9e-05	0.000808	CcSEcCtD
Iloperidone—Gefitinib—ALB—type 2 diabetes mellitus	8.93e-05	0.0297	CrCbGaD
Iloperidone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000801	CcSEcCtD
Iloperidone—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.89e-05	0.000798	CcSEcCtD
Iloperidone—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000798	CcSEcCtD
Iloperidone—Palpitations—Losartan—type 2 diabetes mellitus	8.88e-05	0.000797	CcSEcCtD
Iloperidone—Nausea—Glimepiride—type 2 diabetes mellitus	8.85e-05	0.000795	CcSEcCtD
Iloperidone—Arrhythmia—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000794	CcSEcCtD
Iloperidone—Nausea—Sitagliptin—type 2 diabetes mellitus	8.83e-05	0.000793	CcSEcCtD
Iloperidone—Asthenia—Glyburide—type 2 diabetes mellitus	8.82e-05	0.000792	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.76e-05	0.000786	CcSEcCtD
Iloperidone—Fatigue—Valsartan—type 2 diabetes mellitus	8.74e-05	0.000785	CcSEcCtD
Iloperidone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.73e-05	0.000784	CcSEcCtD
Iloperidone—Oedema—Irbesartan—type 2 diabetes mellitus	8.72e-05	0.000783	CcSEcCtD
Iloperidone—Mental disorder—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000779	CcSEcCtD
Iloperidone—Infection—Irbesartan—type 2 diabetes mellitus	8.66e-05	0.000777	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.65e-05	0.000777	CcSEcCtD
Iloperidone—Fatigue—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000776	CcSEcCtD
Iloperidone—Hypotension—Metformin—type 2 diabetes mellitus	8.63e-05	0.000775	CcSEcCtD
Iloperidone—Malnutrition—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000774	CcSEcCtD
Iloperidone—Myalgia—Losartan—type 2 diabetes mellitus	8.56e-05	0.000768	CcSEcCtD
Iloperidone—Arthralgia—Losartan—type 2 diabetes mellitus	8.56e-05	0.000768	CcSEcCtD
Iloperidone—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000767	CcSEcCtD
Iloperidone—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.000764	CcSEcCtD
Iloperidone—Rash—Bromocriptine—type 2 diabetes mellitus	8.48e-05	0.000761	CcSEcCtD
Iloperidone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.47e-05	0.000761	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.41e-05	0.000756	CcSEcCtD
Iloperidone—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.41e-05	0.000755	CcSEcCtD
Iloperidone—Dry mouth—Losartan—type 2 diabetes mellitus	8.37e-05	0.000751	CcSEcCtD
Iloperidone—Paraesthesia—Metformin—type 2 diabetes mellitus	8.29e-05	0.000745	CcSEcCtD
Iloperidone—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000744	CcSEcCtD
Iloperidone—Confusional state—Losartan—type 2 diabetes mellitus	8.27e-05	0.000743	CcSEcCtD
Iloperidone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.26e-05	0.000742	CcSEcCtD
Iloperidone—Dyspnoea—Metformin—type 2 diabetes mellitus	8.23e-05	0.000739	CcSEcCtD
Iloperidone—Somnolence—Metformin—type 2 diabetes mellitus	8.21e-05	0.000737	CcSEcCtD
Iloperidone—Oedema—Losartan—type 2 diabetes mellitus	8.2e-05	0.000737	CcSEcCtD
Iloperidone—Infection—Losartan—type 2 diabetes mellitus	8.15e-05	0.000732	CcSEcCtD
Iloperidone—Hypotension—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000731	CcSEcCtD
Iloperidone—Tremor—Ramipril—type 2 diabetes mellitus	8.07e-05	0.000725	CcSEcCtD
Iloperidone—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.04e-05	0.000722	CcSEcCtD
Iloperidone—Tachycardia—Losartan—type 2 diabetes mellitus	8.01e-05	0.000719	CcSEcCtD
Iloperidone—Nausea—Bromocriptine—type 2 diabetes mellitus	7.99e-05	0.000717	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.97e-05	0.000716	CcSEcCtD
Iloperidone—Fatigue—Metformin—type 2 diabetes mellitus	7.96e-05	0.000715	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.000713	CcSEcCtD
Iloperidone—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.92e-05	0.000711	CcSEcCtD
Iloperidone—Asthenia—Gliclazide—type 2 diabetes mellitus	7.92e-05	0.000711	CcSEcCtD
Iloperidone—Agitation—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000711	CcSEcCtD
Iloperidone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000703	CcSEcCtD
Iloperidone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000698	CcSEcCtD
Iloperidone—Rash—Glyburide—type 2 diabetes mellitus	7.75e-05	0.000696	CcSEcCtD
Iloperidone—Somnolence—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000696	CcSEcCtD
Iloperidone—Dermatitis—Glyburide—type 2 diabetes mellitus	7.74e-05	0.000695	CcSEcCtD
Iloperidone—Vertigo—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000695	CcSEcCtD
Iloperidone—Leukopenia—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000693	CcSEcCtD
Iloperidone—Hypotension—Losartan—type 2 diabetes mellitus	7.66e-05	0.000688	CcSEcCtD
Iloperidone—Palpitations—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000684	CcSEcCtD
Iloperidone—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.61e-05	0.000683	CcSEcCtD
Iloperidone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.55e-05	0.000678	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000676	CcSEcCtD
Iloperidone—Fatigue—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000675	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.47e-05	0.000671	CcSEcCtD
Iloperidone—Paraesthesia—Losartan—type 2 diabetes mellitus	7.37e-05	0.000661	CcSEcCtD
Iloperidone—Arthralgia—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000659	CcSEcCtD
Iloperidone—Myalgia—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000659	CcSEcCtD
Iloperidone—Dyspnoea—Losartan—type 2 diabetes mellitus	7.31e-05	0.000657	CcSEcCtD
Iloperidone—Nausea—Glyburide—type 2 diabetes mellitus	7.3e-05	0.000656	CcSEcCtD
Iloperidone—Dizziness—Gliclazide—type 2 diabetes mellitus	7.3e-05	0.000655	CcSEcCtD
Iloperidone—Somnolence—Losartan—type 2 diabetes mellitus	7.29e-05	0.000655	CcSEcCtD
Iloperidone—Asthenia—Valsartan—type 2 diabetes mellitus	7.28e-05	0.000653	CcSEcCtD
Iloperidone—Asthenia—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000646	CcSEcCtD
Iloperidone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.000645	CcSEcCtD
Iloperidone—Dry mouth—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000644	CcSEcCtD
Iloperidone—Confusional state—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000637	CcSEcCtD
Iloperidone—Fatigue—Losartan—type 2 diabetes mellitus	7.07e-05	0.000635	CcSEcCtD
Iloperidone—Oedema—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000632	CcSEcCtD
Iloperidone—Rash—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.000625	CcSEcCtD
Iloperidone—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.95e-05	0.000624	CcSEcCtD
Iloperidone—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.94e-05	0.000623	CcSEcCtD
Iloperidone—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000619	CcSEcCtD
Iloperidone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.000619	CcSEcCtD
Iloperidone—Tachycardia—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000616	CcSEcCtD
Iloperidone—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.86e-05	0.000616	CcSEcCtD
Iloperidone—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.76e-05	0.000607	CcSEcCtD
Iloperidone—Dizziness—Valsartan—type 2 diabetes mellitus	6.71e-05	0.000602	CcSEcCtD
Iloperidone—Dizziness—Orlistat—type 2 diabetes mellitus	6.63e-05	0.000595	CcSEcCtD
Iloperidone—Asthenia—Metformin—type 2 diabetes mellitus	6.63e-05	0.000595	CcSEcCtD
Iloperidone—Hypotension—Ramipril—type 2 diabetes mellitus	6.57e-05	0.00059	CcSEcCtD
Iloperidone—Nausea—Gliclazide—type 2 diabetes mellitus	6.56e-05	0.000589	CcSEcCtD
Iloperidone—Body temperature increased—Losartan—type 2 diabetes mellitus	6.48e-05	0.000582	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000575	CcSEcCtD
Iloperidone—Rash—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000574	CcSEcCtD
Iloperidone—Dermatitis—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000574	CcSEcCtD
Iloperidone—Diarrhoea—Metformin—type 2 diabetes mellitus	6.32e-05	0.000567	CcSEcCtD
Iloperidone—Rash—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000567	CcSEcCtD
Iloperidone—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000567	CcSEcCtD
Iloperidone—Dermatitis—Orlistat—type 2 diabetes mellitus	6.31e-05	0.000567	CcSEcCtD
Iloperidone—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000563	CcSEcCtD
Iloperidone—Asthenia—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000562	CcSEcCtD
Iloperidone—Somnolence—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000561	CcSEcCtD
Iloperidone—Dizziness—Metformin—type 2 diabetes mellitus	6.11e-05	0.000548	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000545	CcSEcCtD
Iloperidone—Fatigue—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000544	CcSEcCtD
Iloperidone—Nausea—Valsartan—type 2 diabetes mellitus	6.02e-05	0.000541	CcSEcCtD
Iloperidone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000535	CcSEcCtD
Iloperidone—Nausea—Orlistat—type 2 diabetes mellitus	5.95e-05	0.000534	CcSEcCtD
Iloperidone—Asthenia—Losartan—type 2 diabetes mellitus	5.89e-05	0.000528	CcSEcCtD
Iloperidone—Rash—Metformin—type 2 diabetes mellitus	5.82e-05	0.000523	CcSEcCtD
Iloperidone—Dermatitis—Metformin—type 2 diabetes mellitus	5.82e-05	0.000522	CcSEcCtD
Iloperidone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.8e-05	0.00052	CcSEcCtD
Iloperidone—Dizziness—Irbesartan—type 2 diabetes mellitus	5.76e-05	0.000518	CcSEcCtD
Iloperidone—Diarrhoea—Losartan—type 2 diabetes mellitus	5.61e-05	0.000504	CcSEcCtD
Iloperidone—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000499	CcSEcCtD
Iloperidone—Rash—Irbesartan—type 2 diabetes mellitus	5.5e-05	0.000493	CcSEcCtD
Iloperidone—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000493	CcSEcCtD
Iloperidone—Nausea—Metformin—type 2 diabetes mellitus	5.49e-05	0.000493	CcSEcCtD
Iloperidone—Dizziness—Losartan—type 2 diabetes mellitus	5.42e-05	0.000487	CcSEcCtD
Iloperidone—Nausea—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000465	CcSEcCtD
Iloperidone—Rash—Losartan—type 2 diabetes mellitus	5.17e-05	0.000464	CcSEcCtD
Iloperidone—Dermatitis—Losartan—type 2 diabetes mellitus	5.17e-05	0.000464	CcSEcCtD
Iloperidone—Asthenia—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000453	CcSEcCtD
Iloperidone—Nausea—Losartan—type 2 diabetes mellitus	4.87e-05	0.000437	CcSEcCtD
Iloperidone—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000432	CcSEcCtD
Iloperidone—Dizziness—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000418	CcSEcCtD
Iloperidone—Rash—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000398	CcSEcCtD
Iloperidone—Dermatitis—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000398	CcSEcCtD
Iloperidone—Nausea—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000375	CcSEcCtD
Iloperidone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.64e-06	2.02e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.64e-06	2.02e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.64e-06	2.02e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.64e-06	2.02e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.64e-06	2.02e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.64e-06	2.01e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.64e-06	2.01e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.63e-06	2.01e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.63e-06	2.01e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.63e-06	2e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.62e-06	2e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.62e-06	1.99e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.61e-06	1.99e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.61e-06	1.99e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.61e-06	1.99e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.6e-06	1.98e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.6e-06	1.97e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.6e-06	1.97e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.6e-06	1.97e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.59e-06	1.96e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.59e-06	1.96e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.59e-06	1.95e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.59e-06	1.95e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.58e-06	1.95e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.58e-06	1.95e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	1.58e-06	1.95e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.58e-06	1.94e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.57e-06	1.93e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.57e-06	1.93e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.57e-06	1.93e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.56e-06	1.93e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.56e-06	1.93e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.56e-06	1.92e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.55e-06	1.91e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.55e-06	1.91e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.55e-06	1.9e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.54e-06	1.9e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.54e-06	1.9e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.54e-06	1.9e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.54e-06	1.89e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.53e-06	1.89e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.52e-06	1.88e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.52e-06	1.87e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.52e-06	1.87e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.52e-06	1.87e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.51e-06	1.87e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.51e-06	1.87e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.51e-06	1.86e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.5e-06	1.85e-05	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.5e-06	1.85e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.5e-06	1.84e-05	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.49e-06	1.84e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.49e-06	1.83e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.49e-06	1.83e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.49e-06	1.83e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.49e-06	1.83e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.83e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.48e-06	1.83e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.48e-06	1.82e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.48e-06	1.82e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.48e-06	1.82e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.47e-06	1.81e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.47e-06	1.81e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.47e-06	1.81e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.46e-06	1.8e-05	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.45e-06	1.79e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.45e-06	1.78e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.45e-06	1.78e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.45e-06	1.78e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.44e-06	1.78e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.44e-06	1.77e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.44e-06	1.77e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.43e-06	1.77e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.43e-06	1.76e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.43e-06	1.76e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.42e-06	1.75e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.42e-06	1.75e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.42e-06	1.75e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.42e-06	1.75e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.42e-06	1.74e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.41e-06	1.74e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.41e-06	1.73e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.4e-06	1.72e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.4e-06	1.72e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.39e-06	1.71e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.38e-06	1.7e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	1.38e-06	1.7e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.38e-06	1.7e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.38e-06	1.7e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.38e-06	1.7e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.38e-06	1.69e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.36e-06	1.68e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.36e-06	1.68e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.36e-06	1.67e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.36e-06	1.67e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.35e-06	1.66e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.35e-06	1.66e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.33e-06	1.64e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.32e-06	1.63e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.32e-06	1.63e-05	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.32e-06	1.62e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.31e-06	1.61e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.3e-06	1.61e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.3e-06	1.61e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.3e-06	1.6e-05	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-06	1.6e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.3e-06	1.6e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.3e-06	1.6e-05	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-06	1.59e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	1.59e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.29e-06	1.58e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	1.58e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.28e-06	1.58e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.28e-06	1.57e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.27e-06	1.57e-05	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.27e-06	1.56e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.26e-06	1.56e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.26e-06	1.55e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.26e-06	1.55e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.26e-06	1.55e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.25e-06	1.54e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.25e-06	1.54e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.24e-06	1.53e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	1.52e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.23e-06	1.51e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.23e-06	1.51e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.22e-06	1.51e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.22e-06	1.51e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.22e-06	1.51e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.22e-06	1.5e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.22e-06	1.5e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.22e-06	1.5e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.21e-06	1.5e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	1.49e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.21e-06	1.49e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.48e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.2e-06	1.48e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	1.48e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.2e-06	1.47e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.19e-06	1.47e-05	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.18e-06	1.45e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.18e-06	1.45e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.18e-06	1.45e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-06	1.45e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.18e-06	1.45e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-06	1.45e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.17e-06	1.44e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.17e-06	1.44e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.17e-06	1.44e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.16e-06	1.43e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	1.43e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.15e-06	1.42e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.15e-06	1.42e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.14e-06	1.4e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.14e-06	1.4e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.14e-06	1.4e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	1.39e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.13e-06	1.39e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.12e-06	1.38e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.12e-06	1.38e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	1.38e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.12e-06	1.38e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	1.38e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	1.37e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.11e-06	1.36e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.1e-06	1.35e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.1e-06	1.35e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.09e-06	1.35e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.09e-06	1.35e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.34e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.09e-06	1.34e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	1.34e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.09e-06	1.34e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.09e-06	1.34e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.08e-06	1.33e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.07e-06	1.32e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.07e-06	1.32e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.07e-06	1.32e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.07e-06	1.32e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.06e-06	1.31e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.06e-06	1.3e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.05e-06	1.29e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	1.28e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.04e-06	1.28e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.02e-06	1.26e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	1.25e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.02e-06	1.25e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.01e-06	1.24e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	1e-06	1.23e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-06	1.23e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-06	1.23e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.98e-07	1.23e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.93e-07	1.22e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	9.88e-07	1.22e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	9.82e-07	1.21e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.82e-07	1.21e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.81e-07	1.21e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.8e-07	1.21e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.62e-07	1.18e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	9.6e-07	1.18e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	9.57e-07	1.18e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	9.51e-07	1.17e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	9.41e-07	1.16e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.37e-07	1.15e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	9.37e-07	1.15e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	9.33e-07	1.15e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.27e-07	1.14e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.25e-07	1.14e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.11e-07	1.12e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.1e-07	1.12e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	9.1e-07	1.12e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.94e-07	1.1e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.74e-07	1.08e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	8.69e-07	1.07e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	8.45e-07	1.04e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.32e-07	1.02e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8.16e-07	1.01e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.06e-07	9.92e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.02e-07	9.87e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	8.01e-07	9.86e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.8e-07	9.6e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.67e-07	9.44e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	7.58e-07	9.33e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.55e-07	9.29e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.53e-07	9.27e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.39e-07	9.1e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.34e-07	9.04e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.08e-07	8.71e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.02e-07	8.65e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.02e-07	8.65e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.96e-07	8.57e-06	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	6.96e-07	8.57e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.95e-07	8.56e-06	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	6.94e-07	8.55e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.87e-07	8.45e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.82e-07	8.39e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.42e-07	7.91e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.34e-07	7.8e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.94e-07	6.08e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	4.18e-07	5.15e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.23e-07	3.97e-06	CbGpPWpGaD
